196 related articles for article (PubMed ID: 28144286)
21. Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases.
Reichard KK; Tefferi A; Abdelmagid M; Orazi A; Alexandres C; Haack J; Greipp PT
Blood Cancer J; 2022 Nov; 12(11):147. PubMed ID: 36323674
[TBL] [Abstract][Full Text] [Related]
22. Flow Cytometry Analysis Versus E-Cadherin Immunohistochemistry for the Diagnosis of Pure Erythroid Leukemia: A Case Report.
AlSwayyed A; Salamah B; Al-Moshary M; Hussein Karrar KAE; Khan A
Cureus; 2020 Jul; 12(7):e9055. PubMed ID: 32782874
[TBL] [Abstract][Full Text] [Related]
23. Cytogenetic clonality analysis: typical patterns in myelodysplastic syndrome and acute myeloid leukaemia.
van Lom K; Hagemeijer A; Vandekerckhove F; Smit EM; Löwenberg B
Br J Haematol; 1996 Jun; 93(3):594-600. PubMed ID: 8652379
[TBL] [Abstract][Full Text] [Related]
24. Acute erythroleukemia: diagnosis and management.
Santos FP; Bueso-Ramos CE; Ravandi F
Expert Rev Hematol; 2010 Dec; 3(6):705-18. PubMed ID: 21091147
[TBL] [Abstract][Full Text] [Related]
25. The effects of azacitidine on the response and prognosis of myelodysplastic syndrome and acute myeloid leukemia involving a bone marrow erythroblast frequency of >50.
Uchida T; Hagihara M; Hua J; Inoue M
Leuk Res; 2017 Feb; 53():35-38. PubMed ID: 28013105
[TBL] [Abstract][Full Text] [Related]
26. Anti-CD71 antibody immunohistochemistry in the diagnosis of acute myeloid leukemia, subtype acute erythroid leukemia with erythroid dominance (AML M6-Er), in a retrovirus-negative cat.
Suzuki S; Ogino N; Mitsui I; Ito H; Kariya T
J Vet Diagn Invest; 2021 Jan; 33(1):87-94. PubMed ID: 33225861
[TBL] [Abstract][Full Text] [Related]
27. Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study.
Davey FR; Abraham N; Brunetto VL; MacCallum JM; Nelson DA; Ball ED; Griffin JD; Baer MR; Wurster-Hill D; Mayer RJ
Am J Hematol; 1995 May; 49(1):29-38. PubMed ID: 7741135
[TBL] [Abstract][Full Text] [Related]
28. Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia.
Takeda J; Yoshida K; Nakagawa MM; Nannya Y; Yoda A; Saiki R; Ochi Y; Zhao L; Okuda R; Qi X; Mori T; Kon A; Chiba K; Tanaka H; Shiraishi Y; Kuo MC; Kerr CM; Nagata Y; Morishita D; Hiramoto N; Hangaishi A; Nakazawa H; Ishiyama K; Miyano S; Chiba S; Miyazaki Y; Kitano T; Usuki K; Sezaki N; Tsurumi H; Miyawaki S; Maciejewski JP; Ishikawa T; Ohyashiki K; Ganser A; Heuser M; Thol F; Shih LY; Takaori-Kondo A; Makishima H; Ogawa S
Blood Cancer Discov; 2022 Sep; 3(5):410-427. PubMed ID: 35839275
[TBL] [Abstract][Full Text] [Related]
29. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
30. De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity.
Reinig EF; Greipp PT; Chiu A; Howard MT; Reichard KK
Mod Pathol; 2018 May; 31(5):705-717. PubMed ID: 29327715
[TBL] [Abstract][Full Text] [Related]
31. A case of chronic myeloid leukaemia presenting as megakaryocytic blast crisis (AML M7).
Karkuzhali P; Shanthi V; Usha T
Ecancermedicalscience; 2013; 7():375. PubMed ID: 24282446
[TBL] [Abstract][Full Text] [Related]
32. E-cadherin is a specific marker for erythroid differentiation and has utility, in combination with CD117 and CD34, for enumerating myeloblasts in hematopoietic neoplasms.
Ohgami RS; Chisholm KM; Ma L; Arber DA
Am J Clin Pathol; 2014 May; 141(5):656-64. PubMed ID: 24713736
[TBL] [Abstract][Full Text] [Related]
33. Proposed criteria for classification of acute myeloid leukemia in dogs and cats.
Jain NC; Blue JT; Grindem CB; Harvey JW; Kociba GJ; Krehbiel JD; Latimer KS; Raskin RE; Thrall MA; Zinkl JG
Vet Clin Pathol; 1991; 20(3):63-82. PubMed ID: 12673541
[TBL] [Abstract][Full Text] [Related]
34. Revisiting erythroleukemia.
Arber DA
Curr Opin Hematol; 2017 Mar; 24(2):146-151. PubMed ID: 27875373
[TBL] [Abstract][Full Text] [Related]
35. Pure Erythroleukemia (Variant Acute Myeloid Leukemia-vAML-M6) with Deletion of Chromosome 20, Mainly Presenting as Late Erythroblasts, a Unique Case Report with Review of Literature.
Rasool J; Geelani S; Khursheed ; Yasir ; Lone MS; Shaban M
Indian J Hematol Blood Transfus; 2014 Mar; 30(1):34-7. PubMed ID: 24554819
[TBL] [Abstract][Full Text] [Related]
36. Sub classification and clinico-hematological correlation of 40 cases of acute erythroleukemia - can proerythroblast/myeloblast and proerythroblast/total erythroid cell ratios help subclassify?
Srinivas U; Kumar R; Pati H; Saxena R; Tyagi S
Hematology; 2007 Oct; 12(5):381-5. PubMed ID: 17852448
[TBL] [Abstract][Full Text] [Related]
37. Acute erythremic myelosis (true erythroleukaemia): a variant of AML FAB-M6.
Hasserjian RP; Howard J; Wood A; Henry K; Bain B
J Clin Pathol; 2001 Mar; 54(3):205-9. PubMed ID: 11253132
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapeutics for Acute Erythroid Leukemia: Research, Present and Future.
Liao Z; Li J; Wu J; Liu J; Sun S
Curr Mol Med; 2021; 21(10):819-831. PubMed ID: 33475071
[TBL] [Abstract][Full Text] [Related]
39. [Acute myeloid leukemia with bone marrow erythroblastosis: about one case illustrating the new WHO classification (2008)].
Vincenot A; Abarah W; Frayfer J; Mahfouz I; Andre-Kerneis E
Ann Biol Clin (Paris); 2011; 69(3):343-7. PubMed ID: 21659053
[TBL] [Abstract][Full Text] [Related]
40. Clinical importance of cytogenetics in acute myeloid leukaemia.
Mrózek K; Heinonen K; Bloomfield CD
Best Pract Res Clin Haematol; 2001 Mar; 14(1):19-47. PubMed ID: 11355922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
